GT
HOLX

Glenmede Trust’s Hologic HOLX Stock Holding History

Glenmede Trust’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,902
Closed -$371K – 1529
2026
Q1 		$371K Buy
4,902
+198
+4% +$14.9K ﹤0.01% 1073
2025
Q4 		$350K Buy
+4,704
New +$344K ﹤0.01% 1074
2025
Q1 		$236K Sell
3,828
-3,153
-45% -$209K ﹤0.01% 1163
2024
Q4 		$503K Sell
6,981
-705
-9% -$55.1K ﹤0.01% 934
2024
Q3 		$626K Buy
7,686
+68
+0.9% +$5.44K ﹤0.01% 861
2024
Q2 		$566K Sell
7,618
-460
-6% -$34.5K ﹤0.01% 861
2024
Q1 		$630K Buy
8,078
+266
+3% +$19.8K ﹤0.01% 849
2023
Q4 		$558K Buy
7,812
+1,439
+23% +$100K ﹤0.01% 862
2023
Q3 		$442K Sell
6,373
-52
-0.8% -$3.93K ﹤0.01% 878
2023
Q2 		$518K Hold
6,425
– – ﹤0.01% 818
2023
Q1 		$518K Buy
6,425
+74
+1% +$5.96K ﹤0.01% 822
2022
Q4 		$475K Buy
6,351
+1,324
+26% +$94.3K ﹤0.01% 846
2022
Q3 		$324K Sell
5,027
-192
-4% -$13.3K ﹤0.01% 927
2022
Q2 		$361K Sell
5,219
-409
-7% -$30.4K ﹤0.01% 951
2022
Q1 		$432K Sell
5,628
-557
-9% -$40.1K ﹤0.01% 939
2021
Q4 		$473K Buy
6,185
+454
+8% +$33.4K ﹤0.01% 944
2021
Q3 		$423K Sell
5,731
-305
-5% -$22.9K ﹤0.01% 939
2021
Q2 		$402K Sell
6,036
-261
-4% -$17.4K ﹤0.01% 944
2021
Q1 		$467K Sell
6,297
-54
-0.9% -$4.1K ﹤0.01% 863
2020
Q4 		$461K Buy
6,351
+319
+5% +$22.5K ﹤0.01% 859
2020
Q3 		$400K Buy
6,032
+166
+3% +$10.5K ﹤0.01% 850
2020
Q2 		$334K Buy
5,866
+1,472
+34% +$72.2K ﹤0.01% 871
2020
Q1 		$229K Hold
4,394
– – ﹤0.01% 1153
2019
Q4 		$229K Buy
4,394
+35
+0.8% +$1.74K ﹤0.01% 1153
2019
Q3 		$220 Hold
4,359
– – ﹤0.01% 1133
2019
Q2 		$208 Sell
4,359
-3,149
-42% -$146K ﹤0.01% 1146
2019
Q1 		$363 Buy
7,508
+3,132
+72% +$141K ﹤0.01% 977
2018
Q4 		$178 Buy
4,376
+144
+3% +$5.91K ﹤0.01% 1157
2018
Q3 		$172K Sell
4,232
-968
-19% -$39.1K ﹤0.01% 1192
2018
Q2 		$207K Hold
5,200
– – ﹤0.01% 1058
2018
Q1 		$222K Hold
5,200
– – ﹤0.01% 1147
2017
Q4 		$222K Sell
5,200
-135
-3% -$5.38K ﹤0.01% 1147
2017
Q3 		$194K Sell
5,335
-889,051
-99% -$35.9M ﹤0.01% 1234
2017
Q2 		$38.1M Hold
894,386
– – 0.18% 168
2017
Q1 		$38.1M Buy
894,386
+13,694
+2% +$558K 0.18% 168
2016
Q4 		$35.3M Sell
880,692
-1,442
-0.2% -$55.6K 0.19% 180
2016
Q3 		$34.3M Buy
882,134
+145,211
+20% +$5.48M 0.19% 165
2016
Q2 		$25.5M Buy
736,923
+718,213
+3,839% +$24.9M 0.15% 234
2016
Q1 		$644K Buy
18,710
+13,510
+260% +$471K ﹤0.01% 845
2015
Q4 		$201K Hold
5,200
– – ﹤0.01% 1181
2015
Q3 		$203K Hold
5,200
– – ﹤0.01% 1173
2015
Q2 		$197K Hold
5,200
– – ﹤0.01% 1221
2015
Q1 		$171K Sell
5,200
-260
-5% -$7.98K ﹤0.01% 1300
2014
Q4 		$145K Hold
5,460
– – ﹤0.01% 1418
2014
Q3 		$132K Buy
5,460
+260
+5% +$6.57K ﹤0.01% 1334
2014
Q2 		$131K Hold
5,200
– – ﹤0.01% 1314
2014
Q1 		$111K Sell
5,200
-168
-3% -$3.62K ﹤0.01% 1374
2013
Q4 		$119K Buy
5,368
+168
+3% +$3.7K ﹤0.01% 1339
2013
Q3 		$107K Hold
5,200
– – ﹤0.01% 1350
2013
Q2 		$100K Buy
+5,200
New +$109K ﹤0.01% 1316

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust's HOLX Position: Q2 2026 in Review

Glenmede Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 4,902 shares — an estimated $371K sold.

Glenmede Trust first reported a position in HOLX in Q2 2013 and held it in 50 quarters. The position peaked at $38.1M in Q2 2017. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Glenmede Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Glenmede Trust sold 4,902 Hologic shares in Q2 2026, an estimated $371K.
  • Glenmede Trust first reported a position in Hologic in Q2 2013 and held it in 50 quarters.
  • Glenmede Trust's Hologic position peaked at $38.1M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.